Treatment of hepatitis C virus in the coinfected patient.
Since hepatitis C virus (HCV) was first identified in 1989, the impact of HCV infection on the HIV-infected population has been steadily increasing. It is now known that HCV affects the course and treatment of HIV disease in coinfected individuals (those infected with both HCV and HIV). Although there are significant data regarding the treatment of HCV in non-coinfected individuals, there are numerous questions that still remain regarding how to monitor and treat HCV infection in the coinfected population. This article reviews the available data regarding treatment of HCV in the coinfected population as well as how these individuals should be monitored, before and during HCV therapy, as well as how to address the numerous side effects associated with HCV treatment. To meet the demands of the coinfected population. HIV nurses must be willing to expand their knowledge to support, educate, assess, and advocate for coinfected individuals.
Brennan
Christine
C
Department of Public Health & Preventive Medicine-HIV Outpatient Program, Louisiana State University Health Sciences Center, USA.
D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000451:nursing*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy / Q000451:nursing*; D006801:Humans; D007372:Interferons / Q000008:administration & dosage; D012254:Ribavirin / Q000008:administration & dosage
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons